| Provider | Medication & Dose | Billing | Cycle | Notes | Freshness |
|---|
All figures reflect provider-published pricing as of May 2026. Compounded GLP-1 medications are not FDA-approved. Following the FDA's resolution of declared GLP-1 shortages in 2025, compounded versions may only be prescribed where a licensed provider documents medical necessity. Peptide rows for "research use only" providers are listed for transparency; these vendors do not provide a medical relationship and patients should not use them as a treatment pathway. Eligibility, prescription, and outcomes are determined by the prescribing provider, not by GLP Agonists.